Results 141 to 150 of about 5,988 (201)

Επίδραση των DOACS στις κλασικές δοκιμασίες πήξης στα καρδιαγγειακά νοσήματα

H καρδιαγγειακή νόσος αποτελεί τη κύρια αιτία θανάτου παγκοσμίως. Για την πρόληψη σχηματισμού θρόμβων, στους συγκεκριμένους ασθενείς, που παρουσιάζουν αυξημένο κίνδυνο για θρομβώσεις, χορηγείται αντιπηκτική αγωγή, η οποία για πολλά χρόνια βασιζόταν σε ...
Dimos Evangelos, Δήμος Ευάγγελος   +1 more
core  

Perioperative Resumption of DOACs: The Mayo Experience (RESUME) Review

, 2019
Background: To our knowledge, there are no reports of clinical guidelines that concern the resumption of direct oral anticoagulants (DOACs) after an elective procedure. Recently DOACs (i.e.
Carpenter, Emily
core  

DOAC — not for everyone, and sometimes at different dose

Journal of Transfusion Medicine, 2022
openaire   +2 more sources

ESUSとDOAC

Shinzo, 2020
openaire   +1 more source

Systematic review and meta-analysis of DOACs versus LMWH in Cancer-Associated venous Thrombosis

Introduction: Cancer-associated venous thrombosis (CAT) is a condition associated with highmortality rates. However, limited evidence exists regarding the effectiveness and safety of lowmolecular-weight heparin (LMWH) and direct oral anticoagulants ...
Wong, Ian CK, Huang, Caige, Li, Silvia TH, Chan, Esther Wai Yin, Lau, Rinko Tsz Lam, KANG, Wei, Yang, Yu, Wei, Yue, Yan, Vincent KC, Lee, Kyung Jin   +9 more
core  

Is laboratory monitoring useful in DOACs management?

Mediterranean Journal of Hematology and Infectious Diseases
Mario Biglietto, Rosaria Mormile, Matteo Totaro, Maria Laura Bisegna, Cristina Santoro, Antonio Chistolini   +5 more
openaire   +2 more sources

Accuracy of Direct Oral Anticoagulants (DOAC) Dipstick in patients treated preoperatively with DOAC

Vassart, Julie; id_orcid 0009-0004-2512-7494, Tafur, Alfonso, Boucher, Anne-Yseult, Morimont, Laure, Walenga, Jeanine, Harenberg, Job F., Douxfils, Jonathan; id_orcid 0000-0002-7644-5298   +6 more
openaire   +1 more source

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review

Health Services Insights, 2016
Direct oral anticoagulants (DOACs) are in wide use among patients requiring both short- and long-term anticoagulation, mainly due to their ease of use and the lack of monitoring requirements.
Tagore Sunkara, Madhavi Reddy, Vinaya Gaduputi   +2 more
exaly   +2 more sources

Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges

Current Drug Metabolism, 2017
The Direct Oral Anticoagulants (DOACs) represent a new generation of antithrombotic agents, providing direct inhibition of either thrombin (factor IIa; FIIa) or activated factor X (FXa).
Giuseppe Lippi, Jennifer Curnow
exaly   +2 more sources

DOACs use in extreme body-weighted patients: results from the prospective START-register

Internal and Emergency Medicine, 2023
Background: Direct oral anticoagulants (DOACs) are widely used for the treatment of venous thromboembolism (VTE) and for stroke prevention in atrial fibrillation (AF). However, evidence in obese and underweight patients is limited. We assessed the safety
Walter Ageno, Gualtiero Palareti
exaly   +2 more sources